PACTR201712002827168尚未招募未知
Transfer of healthy gut flora for restoration of intestinal microbiota via enema (THRIVE) for severe acute malnutrition: A pilot study evaluating microbial engraftment, safety and nutritional outcomes
OpenBiome0 个研究点目标入组 20 人开始时间: 2017年11月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Month(s) 至 60 Month(s)(—)
- 性别
- All
入选标准
- •1.Age 18 to 60 months.
- •2.Stable SAM defined as:
- •a.A WHZ of less than ¿3 according to the 2006 WHO Growth Standards or a mid-upper-arm circumference of less than 115 mm
- •b.No medical complications present
- •c.Participant is sufficiently alert and successfully passes the appetite test which involves consumption of breastmilk or a ready to use therapeutic food (RUTF) under supervision.
- •d.Participant is in the rehabilitation phase of treatment for SAM
- •3.No bilateral pitting pedal edema or generalized anasarca.
- •4.HIV negative.
- •5.Optimal WHO treatment for SAM:
- •oCompleted course of antibiotics as part of standard therapy for SAM within the last 3 months.
- •oDeworming in the last 3 months.
- •oMicronutrient supplementation (Vitamin A, zinc and iron) as recommended by local guidelines
- •oNutritional rehabilitation as recommended by local guidelines
- •6.Written informed consent obtained by parent or caregiver.
排除标准
- •1.Evidence of current complicated SAM defined as any of the following:
- •a.Admitted to acute care ward as inpatient
- •b.Signs of acute infection.
- •c.One or more WHO Integrated Management of Childhood Illness danger signs.(2)
- •d.Failure to pass appetite test.
- •e.Presence of known comorbid diseases such as pulmonary Tuberculosis, cystic fibrosis, type I diabetes mellitus, intestinal malabsorptive syndromes, chronic lung disease, chronic liver disease, chronic renal disease or malignancy undergoing active chemotherapy.
- •f.Bilateral pitting pedal edema or generalized anasarca
- •2.Ongoing antibiotic use for indication other than SAM (e.g. infection, HIV prophylaxis).
- •3.Congenital malformations, syndromic conditions and metabolic abnormalities (inborn errors of metabolism) that may adversely affect growth.
- •4.Kwashiorkor or marsmic-kwashiorkor.
- •5.Bilateral pitting edema Grade 2.
- •6.Contraindications to enema:
- •a.Anorectal malformations
- •b.Rectal prolapse
- •c.Hirschsprungs disease
- •d.Other contraindication to enema.
- •7.Primary immune deficiencies
- •8.Neutropenia
- •9.Persistent and chronic diarrhea (>7 days of loose or water stools).
- •10.Dysentery
- •11.Intestinal abnormalities including malformations, Hirschsprungs disease and short bowel syndrome
研究者
相似试验
已完成
2 期
Probiotics to reduce infection in patients admitted to the Intensive Care UnitACTRN12617000783325Fiona Stanley Hospital220
招募中
不适用
Fecal Microbiota Transplantation to Restore Residual Beta Cell Function In Patients With Long- Duration Type 1 Diabetes Mellitustype 1 diabetesNL-OMON27205Amsterdam UMC34
招募中
2 期
Fecal Microbiota Transplantation to Restore Residual Beta Cell Function In Patients With Long-Duration Type 1 Diabetes MellitusType 1 diabetes mellitusinsulin-dependent diabetesjuvenile diabetes10018424NL-OMON49429Academisch Medisch Centrum34
招募中
2 期
Fecal microbiota transplantation for intractable gastrointestinal diseases(FEMIGI study)1)Clostridium difficile infection 2)Crohn disease, ulcerative colitis 3)Chronic Enteropathy associatJPRN-jRCTs041190021Ohmiya Naoki50
招募中
2 期
*Fecal Microbiota Transplantation to Preserve Residual Beta Cell Function In Patients With Newly-Diagnosed Type 1 Diabetes Mellitus: The FMT-Preserve-DM1-trial*Type 1 diabetesjuveline diabetes10018424NL-OMON54931Academisch Medisch Centrum34
